Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

• Status: Completed
• Trial end date: 2001-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

To determine the effects, in postmenopausal women, of hormone replacement therapy on progression/regression of coronary heart disease, as measured by quantitative angiography.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Estradiol; Estrogens; Hormones; Medroxyprogesterone; Medroxyprogesterone Acetate

Criteria

Postmenopausal women with angiographically-documented coronary disease. Approximately 70 percent minority